Bryan T. Hennessy

123 St. Stephen's, Green
Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 158 publications

RETRACTED: Richards et al. Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC). Int. J. Mol. Sci. 2023, 24, 10545.

RETRACTED: Richards et al. Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC). Int. J. Mol. Sci. 2023, 24, 10545.

Journal: International journal of molecular sciences

Published: March 23, 2026

Whole genome sequencing of pre-treatment and post-treatment locally advanced rectal cancer using long and short read technologies.

Whole genome sequencing of pre-treatment and post-treatment locally advanced rectal cancer using long and short read technologies.

Journal: Scientific reports

Published: December 19, 2025

Case Report: Whole-genome sequencing of urothelial carcinoma in an adult patient with CLOVES syndrome reveals a lack of PIK3CA mutation and a genomic landscape consistent with urothelial carcinoma.

Case Report: Whole-genome sequencing of urothelial carcinoma in an adult patient with CLOVES syndrome reveals a lack of PIK3CA mutation and a genomic landscape consistent with urothelial carcinoma.

Journal: Frontiers in oncology

Published: September 12, 2025

A pipeline of machine learning-driven multi-modal data fusion methods for prognostic risk analysis in bevacizumab-treated metastatic colorectal cancer.

A pipeline of machine learning-driven multi-modal data fusion methods for prognostic risk analysis in bevacizumab-treated metastatic colorectal cancer.

Journal: Scientific reports

Published: August 14, 2025

Dose Adjusted Neoadjuvant Paclitaxel, Carboplatin, Trastuzumab and Pertuzumab in Women With HER2 Positive Early Breast Cancer.

Dose Adjusted Neoadjuvant Paclitaxel, Carboplatin, Trastuzumab and Pertuzumab in Women With HER2 Positive Early Breast Cancer.

Journal: Clinical breast cancer

Published: July 02, 2025

Operational determinants of recruitment and biospecimen collection in translational observational studies: a multi-site comparative analysis.

Operational determinants of recruitment and biospecimen collection in translational observational studies: a multi-site comparative analysis.

Journal: Journal of translational medicine

Published: June 20, 2025

Molecular subtyping of endometrial carcinoma cell lines uncovers subtype-specific targetable vulnerabilities.

Molecular subtyping of endometrial carcinoma cell lines uncovers subtype-specific targetable vulnerabilities.

Journal: NPJ precision oncology

Published: April 26, 2025

Prognostic Significance of Delays in Initiation of Adjuvant Trastuzumab-Based Therapy in Patients with HER2-Positive Breast Cancer.

Prognostic Significance of Delays in Initiation of Adjuvant Trastuzumab-Based Therapy in Patients with HER2-Positive Breast Cancer.

Journal: Biomedicines

Published: April 17, 2025

Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors for Patients With Advanced Solid Organ Malignancies.

Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors for Patients With Advanced Solid Organ Malignancies.

Journal: International journal of dermatology

Published: April 14, 2025

Implementation of neoadjuvant immunotherapy in stage III melanoma: a modified Delphi consensus study in a European-accredited cancer center in Ireland.

Implementation of neoadjuvant immunotherapy in stage III melanoma: a modified Delphi consensus study in a European-accredited cancer center in Ireland.

Journal: The oncologist

Published: March 26, 2025

Contrasting roles of KMT2C and KMT2D in breast cancer.

Contrasting roles of KMT2C and KMT2D in breast cancer.

Journal: Scientific reports

Published: March 20, 2025

Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN study.

Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 13, 2025

Showing 1-12 of 158

Last Updated: 09/26/2026